Journal of Pharmaceutical Analysis

作者在投稿时必须声明在稿件准备过程中使用生成式人工智能工具的情况；本刊允许作者在人工监督与控制下使用人工智能工具辅助写作，但此类工具绝不能替代人类的批判性思维、专业知识和评估。 模型中文摘要

Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…

为提高透明度，本刊要求通讯作者使用CRediT分类（包含概念化、数据管理、形式分析、经费获取、调查研究、方法学、项目管理、资源、软件、监督、验证、可视化、初稿撰写及审阅与编辑共14种角色）提供各合著者对稿件的具体贡献。 模型中文摘要

For transparency, we require corresponding authors to provide co-author contributions to the manuscript using the relevant CRediT roles. The CRediT taxonomy includes 14 different roles describing each contributor's specific contribution to the scholarly output. The roles are: Conceptualization; Data curation; Formal analysis; Funding acquisition; Investigation; Methodology; Project administration;…

所有作者必须披露可能不当影响其工作的任何财务或个人关系（如雇佣、咨询、持股、酬金、有偿专家证言、专利申请/注册及资助等），并须在两处披露：标题页文件或稿件文件中的利益声明摘要（无利益可声明时写“Declarations of interest: none”），以及作为期刊正式记录一部分的单独利益声明表。 模型中文摘要

All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Authors must disclose any interests in two places:…

文章被接受后，作者需签署“期刊出版协议”，确认版权事宜；作者（或其雇主/机构）对再利用自己的作品享有一定权利。 模型中文摘要

Upon acceptance of an article, authors will be asked to complete a 'Journal Publishing Agreement' (for more information on this and copyright, see https://www.elsevier.com/copyright). An e-mail will be sent to the corresponding author confirming receipt of the manuscript together with a 'Journal Publishing Agreement' form or a link to the online version of this agreement.Author rightsAs an author …

有关本刊开放获取出版的更多信息，请访问开放获取页面。 模型中文摘要

Please visit our Open Access page for more information about open access publishing in this journal.

本刊实行双盲匿名审稿；稿件先由编辑评估是否适合本刊，被认为合适的稿件通常送至少两名独立专家审稿人评估科学质量，编辑对接受或拒绝拥有最终决定权，且编辑不参与与自己或亲属、同事相关或涉及自身利益产品的稿件决策。 模型中文摘要

This journal operates a double anonymized review process. All contributions will be initially assessed by the editor for suitability for the journal. Papers deemed suitable are then typically sent to a minimum of two independent expert reviewers to assess the scientific quality of the paper. The Editor is responsible for the final decision regarding acceptance or rejection of articles. The Editor'…

预印本可随时在任何地方共享，符合Elsevier的共享政策；在预印本服务器上共享预印本不会被视为先前发表。 模型中文摘要

Please note that preprints can be shared anywhere at any time, in line with Elsevier's sharing policy. Sharing your preprints e.g. on a preprint server will not count as prior publication (see 'Multiple, redundant or concurrent publication' for more information).